The specimen validity testing market was estimated at USD 1.34 billion in 2022 and is likely to grow at a CAGR of 6.39% during 2023-2028 to reach USD 1.95 billion in 2028.
Specimen validity tests, also known as testing for nitrates or Test Sure, are performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. A drug-testing program detects people who have used drugs. The test determines whether a urine specimen has been adulterated, diluted, or substituted.